Ligand profile
ZINC74148213
Virtual-screening candidate from ZINC.
Bound to: VK055_2602 — ribosomal-protein-alanine acetyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC74148213- UniProt (similar protein)
Q9GZZ1- Tanimoto
- 0.500
- Target protein
- VK055_2602
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 49.3
- −1 ≤ LogP ≤ 5 2.02
- MW ≤ 500 Da 211.3
- LogP ≤ 5 2.02
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 49.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(O)[C@H]1C[C@@H](C2CCCCC2)CCN1O=C(O)[C@H]1C[C@@H](C2CCCCC2)CCN1
InChI=1S/C12H21NO2/c14-12(15)11-8-10(6-7-13-11)9-4-2-1-3-5-9/h9-11,13H,1-8H2,(H,14,15)/t10-,11+/m0/s1InChI=1S/C12H21NO2/c14-12(15)11-8-10(6-7-13-11)9-4-2-1-3-5-9/h9-11,13H,1-8H2,(H,14,15)/t10-,11+/m0/s1
HRHIKSLSMMWSSH-WDEREUQCSA-NHRHIKSLSMMWSSH-WDEREUQCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- PRO
- Homolog
- Q9GZZ1
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC74148213 →
- ZINC ZINC20 ZINC74148213 →
- UniProt UniProt Q9GZZ1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC74148213”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2602.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 10
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).